Order Article Reprints

Salati M, De Ruvo N, Giglio MC, Sorrentino L, Esposito G, Fenocchi S, Cucciarrè G, Serra F, Rossi EG, Vittimberga G, et al. Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST. Journal of Clinical Medicine. 2022; 11(18):5439. https://doi.org/10.3390/jcm11185439

Salati, Massimiliano, Nicola De Ruvo, Mariano Cesare Giglio, Lorena Sorrentino, Giuseppe Esposito, Sara Fenocchi, Giovanni Cucciarrè, Francesco Serra, Elena Giulia Rossi, Giovanni Vittimberga, and et al. 2022. "Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST" Journal of Clinical Medicine 11, no. 18: 5439. https://doi.org/10.3390/jcm11185439

Salati, M., De Ruvo, N., Giglio, M. C., Sorrentino, L., Esposito, G., Fenocchi, S., Cucciarrè, G., Serra, F., Rossi, E. G., Vittimberga, G., Radi, G., Solaini, L., Morgagni, P., Grizzi, G., Ratti, M., Gelsomino, F., Spallanzani, A., Ghidini, M., Ercolani, G., ... Gelmini, R. (2022). Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST. Journal of Clinical Medicine, 11(18), 5439. https://doi.org/10.3390/jcm11185439